Home Conference News Announcing New Conference Reports Partnership with Annals of the New York Academy...

Announcing New Conference Reports Partnership with Annals of the New York Academy of Sciences

-

We are delighted to announce a new partnership with the Annals of the New York Academy of Sciences to publish conference reports from select Keystone Symposia meetings! https://nyaspubs.onlinelibrary.wiley.com/journal/17496632

The collaboration will enable broader audiences worldwide to access novel discoveries and emerging research directions shared at our conferences.  Documenting these advances in the publication record will accelerate progress and innovation for those beyond the small circles of meeting attendees, to advance the pursuit of science as a whole, across many fields.

Read the latest conference reports here:

https://nyaspubs.onlinelibrary.wiley.com/journal/17496632/keystone-symposia


These meetings are also available for OnDemand viewing!


Below we catch up with Dr. Douglas Braaten, PhD, Editor-in-Chief of Ann. N.Y. Acad. Sci. about what inspired this new partnership:

  1. Why did you initiate this collaboration?  

Dr. Braaten: Ann. N.Y. Acad. Sci. has been publishing conference reports for several years, largely for conferences and symposia at NYAS.  I thought of initiating this collaboration with Keystone Symposia because the reports have been well-received by our worldwide readership and I was naturally drawn to Keystone Symposia for both the topics covered and world-leading scientists at their annual events.  I have also greatly appreciated first-hand Keystone Symposia as a researcher in virology and immunology.  So, I had a clear idea that this type of publication could help promote the stellar science presented at Keystone Symposia events.  

  1. Did the circumstances of the COVID-19 pandemic have any role in the idea?

Dr. Braaten: Planning for the collaboration took place in the second half of 2020, just as the COVID-19 crisis was deepening.  And as everyone was turning to virtual meetings and events— including Keystone’s impressive eSymposia virtual format—we realized that written, published reports would be a great additional way to disseminate Keystone’s scientific discussions.

  1. How do the aims and mission of Ann. N.Y. Acad. Sci. align with Keystone Symposia’s mission?  What makes us a good team?

Dr. Braaten:

The mission of Ann. N.Y. Acad. Sci. is to provide multidisciplinary perspectives on research of current scientific interest with far-reaching implications for the wider scientific community and society at large.  This nicely dovetails with Keystone Symposia’s mission.

  1. How will the conference reports benefit your readers?

Dr. Braaten: We certainly hope that the reports benefit all our readers, and hopefully will bring new ones to Ann. N.Y. Acad. Sci., as well as increased interest in Keystone Symposia events.  At the very least, we hope to provide another way for scientists—especially those who cannot travel—to participate in Keystone Symposia. 

  1. Does Ann. N.Y. Acad. Sci. focus on any topics in particular?  Why did you choose these meetings specifically to highlight?

Dr. Braaten: Ann. N.Y. Acad. Sci. is ranked in the multidisciplinary sciences category on Clarivate’s Journal of Citation Reports, alongside NatureScience, and PNAS. Papers on a wide range of topics in the biological sciences are submitted to Ann. N.Y. Acad. Sci.  The specific Keystone Symposia covered in the first set of reports were chosen because they run the gamut from neuroscience to plant genetics.

  1. What’s next for the partnership? 

Dr. Braaten: In 2021 we will publish ten reports, with a print special issue by end of the calendar year.  In 2022 (and beyond), we hope to expand coverage to more—or even all—of Keystone Symposia’s portfolio for a given year.  

  1. Anything else you would like to share with our audience?

Dr. Braaten: Over its nearly 200-year history, Ann. N.Y. Acad. Sci. has been a staple of scientific publishing—it’s the oldest continuously published scientific journal in the U.S.  And over those many years, some of the most highly cited papers have been published in Ann. N.Y. Acad. Sci. 

The collaboration with Keystone Symposia is the newest addition to our long tradition of presenting the best science by the top scientists from around the globe.  I could not be more excited by the opportunity to add a new, lasting element to both our scientific organizations.

Find out more here:

https://nyaspubs.onlinelibrary.wiley.com/journal/17496632

Annals of the New York Academy of Sciences is an international science journal published bi-monthly by John Wiley & Sons for the New York Academy of Sciences. First published in 1824, Ann. N.Y. Acad. Sci. publishes Original Research Articles and Review, Commentary, and Perspective Articles in many areas of science, though predominantly the biological sciences. Each issue stimulates new ways of thinking about science by providing a neutral forum for discourse—within and across many institutions and fields. Available in over 80 countries worldwide, Ann. N.Y. Acad. Sci. is a hybrid journal (with content available by both subscription and Open Access), is rigorously peer reviewed, and is ranked among the top multidisciplinary journals worldwide [2020 Journal Citation Reports (Clarivate Analytics): 13/73 (Multidisciplinary Sciences)].  

Connect on Twitter: @NYASsciences #NYASAnnals

Publisher Wiley: @WileyNeuro

Shannon Weiman
Shannon Weiman earned her PhD in Biomedical Sciences from the University of California, San Diego, specializing in microbiology and immunology. Prior to joining the Keystone Symposia team, she worked as a freelance writer for leaders in academic, industry and government research, including Stanford University’s Biomedical Innovation Initiative, the University of Colorado’s Biofrontiers Program, UCSF, the FDA and the American Society for Microbiology.
 

Keystone Symposia on Molecular and Cellular Biology is a 501(c)(3) nonprofit organization with a 47-year history of convening open, peer-reviewed conferences that connect the scientific community and accelerate life science discovery.